How does MDKM's pb Ratio compare to its peers?

Insufficient data to calculate MDKM's Price-To-Book Ratio vs. peers for valuation analysis.

How does MDKM's pb Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate MDKM's Price-To-Book Ratio vs. industry for valuation analysis.

What is MDKM's pb Ratio compared to its Fair pb Ratio? This is the expected pb Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MDKM's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of MDKM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate MDKM's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

MDEChem (OTCPK:MDKM) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

MDKM Stock Overview

Provides pharmaceutical and chemical products. More details

MDKM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($10)

Latest financial reports are more than a year old

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

MDEChem, Inc. Competitors

Plant-Based Investment

OTCPK:CWWB.F

US$27.0

PLx Pharma Winddown

OTCPK:PLXP.Q

US$30.0

MJ Holdings

OTCPK:MJNE

US$17.5k

RVL Pharmaceuticals

OTCPK:RVLP.Q

US$111.0

Price History & Performance

Summary of share price highs, lows and changes for MDEChem
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.001
52 Week Low	US$0.000001
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	0%
3 Year Change	n/a
5 Year Change	-99.95%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	MDKM	US Pharmaceuticals	US Market
7D	n/a	0.6%	-0.4%
1Y	0%	-1.1%	20.8%

Return vs Industry: MDKM underperformed the US Pharmaceuticals industry which returned 9.1% over the past year.

Return vs Market: MDKM underperformed the US Market which returned 27.3% over the past year.

Price Volatility

Is MDKM's price volatile compared to industry and market?
MDKM volatility
MDKM Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.8%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.0%
10% least volatile stocks in US Market	3.1%

Stable Share Price: MDKM's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MDKM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1996	n/a	n/a	www.mdechem.com

MDEChem, Inc. provides pharmaceutical and chemical products. The company offers MaxHeal skin restoration gel, a non-steroidal and anti-inflammatory compound that provides instant relief to minor cuts, scrapes, minor burns, sunburn, and abrasions, as well as soothe itchy bites from chiggers, mosquitoes, sand fleas, black flies, and other biting insects. It also provides SANDKLENE 950, a non-toxic chemical composition, which is used in the recovery of oil from tar/oil sands.

MDEChem, Inc. Fundamentals Summary

How do MDEChem's earnings and revenue compare to its market cap?
MDKM fundamental statistics
Market cap	US$10.00
Earnings (TTM)	US$91.55k
Revenue (TTM)	US$200.63k

0.0x

P/E Ratio

0.0x

P/S Ratio

Is MDKM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDKM income statement (TTM)
Revenue	US$200.63k
Cost of Revenue	US$38.44k
Gross Profit	US$162.19k
Other Expenses	US$70.64k
Earnings	US$91.55k

Last Reported Earnings

Mar 31, 2012

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MDKM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 16:09
End of Day Share Price	2024/12/16 00:00
Earnings	2012/03/31
Annual Earnings	2011/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MDEChem, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.